Hiroki Higashihara

Papers

Total Citations

H-Index

About

Dr. Hiroki Higashihara is a leading urologic oncologist whose research centers on nephron-sparing treatments for renal cell carcinoma (RCC), with a particular focus on comparing minimally invasive surgical and ablative techniques. His most cited work, a 2021 study on "Therapeutic and Clinical Outcomes of Robot-assisted Partial Nephrectomy Versus Cryoablation for T1 Renal Cell Carcinoma" (19 citations), provides critical comparative data on oncological outcomes and renal function preservation between robot-assisted partial nephrectomy (RAPN) and percutaneous cryoablation (PCA). This retrospective analysis of 126 patients addresses a significant gap in the literature, offering evidence-based guidance for treatment selection in cT1 RCC. Dr. Higashihara's contributions are particularly valuable in the evolving landscape of nephron-sparing surgery, where balancing cancer control with kidney function is paramount. His work has been cited by peers seeking to optimize patient outcomes, demonstrating its practical impact on clinical decision-making. Through rigorous comparative effectiveness research, Dr. Higashihara continues to advance the field of urologic oncology, helping surgeons and patients navigate the complex trade-offs between surgical resection and ablation.